๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Analysis of Treatment And Prognosis of 134 Thymic Carcinoma Patients

โœ Scribed by Zhai, Y.; Feng, Q.F.; Ji, W.; Hui, Z.G.; Liang, J.; Zhou, Z.M.; Fan, C.C.; Wang, L.H.

Book ID
123321465
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
39 KB
Volume
81
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Treatment and prognosis of primary thymi
Treatment and prognosis of primary thymic carcinoma
โœ Dr. Tokujiro Yano; Nobuyuki Hara; Yukito Ichinose; Hiroshi Asoh; Hideki Yokoyama ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 359 KB

## Abstract From 1972 to 1990, we treated eight cases of thymic carcinoma (6 squamous cell and 2 small cell carcinomas). According to the classification by Masaoka et al., they consisted of one stage I, four stage III, one stage IVa, and two stage IVb. A complete resection of the primary tumor coul

Treatment and prognosis of thymic carcin
Treatment and prognosis of thymic carcinoma : A retrospective analysis of 40 cases
โœ Kazuhiko Ogawa; Takafumi Toita; Takashi Uno; Nobukazu Fuwa; Yasumasa Kakinohana; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB

## Abstract ## BACKGROUND Thymic carcinomas are rare neoplasms, and information regarding the results of treatment and possible prognostic factors in patients with these tumors is limited. ## METHODS The records of 40 patients with histologically confirmed thymic carcinoma who were treated betwe

Treatment and prognosis of metastatic ca
Treatment and prognosis of metastatic carcinoma of unknown primary: Analysis of 100 patients
โœ Alberts, A. S. ;Falkson, G. ;Falkson, H. C. ;van der Merwe, M. P. ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 387 KB

One hundred patients with metastatic carcinoma of unknown primary were analyzed to assess the importance of prognostic factors on survival. Patients were treated with cytostatic combinations, single drugs, or symptomatic care only. Response in the treatment groups ranged from 10% to 33%. The median